Baicheng Medicine: It is expected that the net profit in the first half of 2025 will decrease by 95.53%-100.00% compared to the same period.

Bai Cheng Pharmaceutical announcement, it is expected that the net profit attributable to the shareholders of the listed company from January 1, 2025 to June 30, 2025 will be 0 million to 600 million yuan, a year-on-year decrease of 95.53% to 100.00%. The net profit in the same period of the previous year was 134 million yuan. The net profit after deducting non-recurring gains and losses is expected to be a loss of 9 million to 15 million yuan, compared to 123 million yuan in the same period of the previous year. The company expects the impact of non-recurring gains and losses on net profit to be approximately 15 million yuan, mainly from government subsidy income.